NCT05880056View on ClinicalTrials.gov

Study of Bisoprolol (Nerkardou - Nerhadou International) 5 and 10 mg Oral Dissolvable Film (ODF) Treatment in Egyptian Patients With Essential Hypertension

PHASE4RecruitingINTERVENTIONAL

Enrollment

406

Participants

Timeline

Start Date

August 8, 2024

Primary Completion Date

April 1, 2025

Study Completion Date

April 1, 2025

Conditions

Essential Hypertension

Interventions

DRUG

Nerkardou (5 mg) & (10 mg)

Bisoprolol oral dissolved film ODF(5 mg): equivalent to 5 mg of bisoprolol fumarate Bisoprolol oral dissolved film ODF (10 mg): equivalent to 10 mg of bisoprolol fumarate.

Trial Locations (1)

63611

RECRUITING

Al-Fayoum University Hospital, Al Fayyum

All Listed Sponsors

collaborator

Nerhadou International for pharmaceutical & Nutraceutical, Egypt

UNKNOWN

lead

Genuine Research Center, Egypt

INDUSTRY